Age-Adjusted Dosing Strategies in Clinical Trials
Age-Adjusted Dosing Strategies in Clinical Trials Designing and Applying Age-Adjusted Dosing in Clinical Trials Why Dosing Must be Adjusted for Age Pharmacokinetics (PK) and pharmacodynamics (PD) vary significantly across age groups. In pediatrics, immature liver enzymes and underdeveloped renal clearance can lead to slower drug metabolism and elimination, while in geriatrics, age-related organ decline can…
Read More “Age-Adjusted Dosing Strategies in Clinical Trials” »